Objective: To examine outcome and explore for prognostic markers in a cohort Ͻ10 years following neonatal seizures.
Seizures in the newborn period are the most frequent, distinctive, and often the only clinical sign of neurologic dysfunction in neonates. Irrespective of immediate attempts to suppress the seizures with antiepileptic drugs (AEDs), their presence may signify substantial risk for subsequent neurodevelopmental deficits and death. [1] [2] [3] The relationship between clinical paroxysmal episodes and electrographic seizure activity was explored with synchronous EEG/video monitoring in the 1980s, leading to meaningful temporal electroclinical correlates 4 and more refined clinical diagnoses even in the absence of concomitant ictal EEGs. A prospective population-based study from Newfoundland, Canada, that incorporated these criteria reported an incidence of 2.6/ 1,000 live births for clinical neonatal seizures (CLNESZ). 5 The National Collaborative Perinatal Project (NCPP) has been the closest approximation to a population-based study on outcome in the field. 6 Current populations with CLNESZ may not be identical with the NCPP population due to several factors: 1) refined criteria for clinical diagnosis 4 ; 2) increased survival of premature infants with their increased prevalence of intraventricular hemorrhages (IVH) 7 ; and 3) reduction in hypocalcemic seizures, with their favorable outcome, from around 30% during the 1950s and 1960s 8, 9 to 4% in the early 1990s. 5, 10 Our objective was to examine the functional status of school-aged youth who experienced CLNESZ, defined as paroxysmal behaviors with high specificity for epileptic seizures, 4 in the population-based cohort from Newfoundland, 5 as well to explore for prognostic markers. We hypothesized a relatively low rate of normal outcomes, with a shift in the death to disability patterns for preterm infants in keeping with their increased survival.
11
METHODS Included in this prospective cohort was the entire population of live births in Newfoundland in the 5 years January 1, 1990, to December 31, 1994 (n ϭ 34,615 babies), among whom 90 were diagnosed with CLNESZ up to 44 weeks gestational age (GA). 5 To improve and streamline seizure recognition prestudy training was provided to nursing staff and pediatricians at the six obstetrical units and the single tertiary neonatal intensive care unit (NICU) across Newfoundland. These video-assisted sessions also covered the practice and diagnostic significance of stimulation and restraining maneuvers. Entry criteria for paroxysmal behaviors with high specificity for true epileptic seizures 4 included the following: clonic, myoclonic generalized, and tonic focal (including lateral eye deviation) presentations. Generalized stiffening, subtle motor, apneas or autonomic phenomena were included when present along with other paroxysmal types, except for one neonate with pure generalized tonic and one with only subtle motor presentations which were judged clinically as true seizures. Routine practice throughout the province was for all neonates with seizures to be transferred to the NICU at the tertiary pediatric hospital. The study design did not require temporal ictal EEG recordings. Neonatal EEGs were obtained based on clinical indications and were interpreted by four neurologists attached to the children's hospital. Imaging in the neonatal period included cranial ultrasounds and CT scans, while MRIs were performed later in selected patients. Phenobarbital was invariably the first drug chosen to treat seizures, followed if necessary by phenytoin and benzodiazepines. The children were followed to their late childhood by one or more of the following services: pediatric neurology, the provincial perinatal follow-up program, developmental pediatrics, or the provincial children's rehabilitation center partly on their traveling clinics across the island. Because these programs were overlapping and redundantly inclusive, any infants who had been discharged from the NICU and who failed to show up for their initial and subsequent follow-up appointments were believed to have been normal or to have died. In 2004/2005 we collected data on mortality, physical disability (cerebral palsy [CP] in children was confirmed after infancy), cognitive impairment (confirmed after infancy), learning disability (LD) during school age, other neurologic impairments, and post neonatal epilepsy. Normal outcome was only defined as the absence of intellectual and physical impairment. These outcomes were correlated with seizure types, GA at delivery, birth weight (BW), the main underlying conditions (including results from later testing), neonatal EEGs, and whether neonates received one or more AEDs. A ventriculoperitoneal shunt in a developmentally normal child was not regarded as impairment.
Statistical analysis was performed with SPSS v 12.0 (Chicago, IL). We used 2 and two-tailed Fisher exact tests to compare categorical variables. The Kaplan-Meier approach was used for graphical display of survival.
RESULTS
Follow-up data were available on 82/90 subjects. We added six of the missing children: three with catastrophic neonatal course, whom we presume had died; and three with benign neonatal course, whom we considered to have had a normal outcome. These 62 term and 26 premature infants were the subjects for our analysis. The median BW of the premature infants was 1,590 g (IQR ϭ 1,142), and median GA 32 weeks (IQR ϭ 8.5). Median follow-up age for survivors was 10 years (IQR ϭ 7). Twelve were discharged from follow-up as normal prior to reaching 8 years. Seven survivors with impairment had their last follow-up prior to the age of 8 years due to relocation outside the province.
Normal outcome was present in 31 children (35%); 36 (41%) remained alive with neurodevelopmental impairments and 21 (24%) died (table  1) . GA was a better predictor of outcome than BW. Term infants had a better chance of normal outcome compared to preterm infants ( 2 ϭ 9.08, df ϭ 1, p ϭ 0.003). If we were to consider mild cognitive deficits within the normal group our fig-
Figure 1
Survival curve for term and preterm infants ures would look better with 40 (45%) children deemed normal and 27 (31%) with disability for the total cohort; 36 (58%) normal and 16 (26%) with disability for term infants; and 4 (15%) normal for preterm infants. The median age at death was 13 months (IQR ϭ 66, range: 2 days to 14 years). Figure 1 presents the time course and cumulative risk of death for term and preterm infants. There were no significant differences in gender among the outcome groups. Postneonatal epilepsy (figure 2) developed in 27/79 children (34%), including 29% (17/58) of term and 48% (10/21) of preterm infants. Twenty-five children developed remote symptomatic epilepsy, of whom 22 had additional comorbidities including four with infantile spasms. Median age at epilepsy onset in term infants was 9 months (IQR ϭ 51.5) and for preterm infants was 4 months (IQR ϭ 36). The 10 children with epilepsy who died had additional mental retardation (MR) and CP. Of the 17 who survived 8 term and 3 preterm infants had ongoing epilepsy. Epilepsy in association with CP or MR was closely correlated with early death (two-tailed Fisher exact test p ϭ 0.0337). CP ( figure 3) (table 1) . Infections (19% of the cohort) resulted in normal outcome only in term babies; neurodevelopmental impairments or deaths were invariably associated with prematurity or congenital cytomegalovirus infections. Outcome of patients with cerebral dysgenesis (10% of infants) and complicated IVH resulted in death or sequelae. Of the five children with undetermined etiology two were normal and three had LD. One of these latter children also had hypotonia and motor delay. CP ϭ cerebral palsy; MR ϭ mental retardation; LD ϭ learning disorder. Neonatal interictal EEGs were available on 70 neonates Ͼ32 weeks GA; 34 were normal and 36 were abnormal. Abnormal neonatal EEGs, almost invariably with abnormal background activity, correlated closely with impaired outcome that extended beyond pure LD (Fisher exact test: p Ͻ 0.0001). In 56 neonates no overt clinical seizures were observed following the administration of phenobarbital while 23 neonates received additional AEDs to treat the ongoing CLNESZ; 18 out of the 23 receiving additional AEDs (a suspected marker for more difficult to control seizures) had outcome with impairments beyond pure LD (twotailed Fisher exact test: p ϭ 0.015).
Twenty-two infants had only one type of CLNESZ while the rest had multiple seizure components. Of these different components (table 2) , pure clonic behavior without involvement of the face was present at the extreme ends of the outcome spectrum: mostly unilateral (n ϭ 7) in term infants with normal outcome (n ϭ 4) or term infants with disability but without MR (n ϭ 5) at one end, and on the other, generalized seizures with all limbs in three extremely premature infants who did not survive. We believe that the latter three had rhythmic myoclonic rather than clonic seizures. Apparently pure clonic behavior without facial involvement or other paroxysmal behaviors was associated with more favorable outcome (two-tailed Fisher exact test: p ϭ 0.011) calculated for all infants. None of the seven premature babies with myoclonic seizures, either as a component of mixed seizure presentation or pure generalized myoclonic seizures, survived (median GA of 27 of weeks), comprising 64% of the deceased premature neonates (two-tailed Fisher exact test: p ϭ 0.0005). We did not find any differences in prognosis between subtle motor automatisms (excluding horizontal eye deviations), apnea, or autonomic features. Neither subtle seizures nor generalized tonic seizures were predictive of outcome. The number of seizures or number of seizure behaviors was also not correlated with outcome. DISCUSSION Unresolved issues in seizure recognition, seizure terminology, relationships to the underlying brain pathology, and to paroxysmal EEG abnormalities may hamper clinical research in neonatal seizures. Recommendations to evaluate the prognosis following neonatal seizures have included 1) prospective clinical ascertainment of neonatal seizures without the requirement for EEG monitoring; 2) uniform training for standardized seizure recognition; 3) targeting all live births within a well-defined geographic region over a specific time period; 4) defining the neonatal period up to 44 weeks GA; and 5) follow-up into school years. 10, 13 The NCPP and this cohort are more representative of the challenge of assessing outcomes of neonatal seizures than hospital-based or retrospective reports. Both studies were identified from a large population of live births unselected for the presence of neonatal seizures and the children were followed prospectively for 7 years or longer. These studies were conducted 30 years apart and differ in terms of cohort type, patient ascertainment, seizure definition, frequencies of the underlying conditions, and the life expectancy of preterm babies. We share the contention 13 that capturing ictal events on EEG as an entry requirement for outcome studies may introduce selection bias in favor of the more severely affected infants or infants seen in centers with specialized resources. Hence our reliance on clinical entry criteria is more likely to Figure 2 Epilepsy outcome MR ϭ mental retardation; CP ϭ cerebral palsy.
Figure 3
Prevalence of epilepsy, mental retardation (MR), and cerebral palsy (CP) in the cohort be representative of the real world of neonatal seizures. Adding the six missing children with predictable outcomes to the analysis within the context of the enclosed health system in Newfoundland is likely to reflect more accurate results than leaving them out. We believe that the mixed urban and rural newborn population of Newfoundland is likely representative of that of other regions in developed countries and that extrapolation of these data could provide an approximation of the natural history in children following neonatal seizures. The relatively poor prognosis in our cohort may be due to the reduction in prevalence of hypocalcemic seizures, increased survival among preterm infants, as well as including all cognitive deficits in our outcome analysis. The 12% normal outcome among premature infants is lower than in most hospital-based studies 1, [13] [14] [15] [16] [17] and may represent actual outcome for preterm babies delivered in community hospitals or level II obstetrical units and transported to a tertiary care center. Premature infants with seizures are at an increased risk for death (42%) and impairment (46%), compared to term populations. These results differ from earlier 1,2 conclusions that although the frequency of seizures and neonatal mortality increased with the degree of prematurity, outcome for the survivors was not different than that for term infants with seizures. We interpret these differences as being due to the gradual shift from death to morbidity in premature infants with seizures, exemplified by the difference in mortality from the NCPP era where two-thirds of preterm babies died in the neonatal period, 6 in contrast to this cohort in which the mortality rate among preterm infants was down (42%) and the median mortality age of those who died was 13 months.
Epilepsy was primarily remote symptomatic and often associated with comorbidities. These latter subjects either died or continued to have active epilepsy with only 23% chance for early remission. The risk for developing epilepsy following neonatal seizures is about 40 times greater, and that for infantile spasms 18 about 100 times greater, than in the normal population, with preterm infants being specifically at increased risk, and with an earlier age at onset.
CP was present in 35% of children who survived infancy, and due to later death in 25% of survivors at 13 years, compared to 12% in survivors of the NCPP. These results are in keeping with a rising trend for CP with decreasing gestation at delivery in developed countries, parallel to the decline in extreme preterm infant mortality. 11 We do not have data to analyze the severity of CP, although our group might follow the general trend that current survivors are more severely affected with CP.
11 MR was present in 32% of children who survived infancy, and 20% (due to later death) of survivors compared to 17% MR in survivors of the NCPP. Low BW and GA have been correlated previously with decrease in cognitive test scores, 19 and may explain the relative increase in MR despite advances in newborn care.
In this study neonatal encephalopathy 20 continued to dominate as a related factor at 42%, although less than in most hospital-based studies, 1, [13] [14] [15] while infections (19%), cerebral dysgenesis (10%), and benign familial neonatal seizures with a positive family history (5%) were relatively more frequent. Our results confirm the impression that the severity of the underlying disorder (e.g., neonatal encephalopathy Sarnat stages II vs III 12 ), probably in concert with the critical period of the brain injury 21 (e.g., term vs preterm for bacterial infections), are the major determinants underlying outcome following neonatal seizures. 14, 16 This supposition is in keeping with animal studies where specific stages in brain development influence the response to and expression of an intrauterine pathologic process. This pathologic effect appears to be more profound in mid than late gestation resulting in different patterns and often more severe brain injury in the preterm brain. 21 The contribution of these factors to the neurodevelopmental outcome may well be accentuated by metabolic stress and injury produced by the seizures in combination with hypoxia and possibly other acute encephalopathies. 22, 23 Two seizure types were closely associated with outcome. Myoclonic generalized seizures alone or with other behaviors in the preterm infant were associated with death, while myoclonic seizures in a single term infant were associated with only mild impairment. These findings suggest different underlying mechanisms for certain seizure types at different GAs. Clonic seizures were more common in term infants. Clonic seizures, unilateral (n ϭ 5) or bilateral (n ϭ 2), without facial involvement and without other seizure components were seen only in term infants and may be associated with favorable outcome. We are not convinced that this subgroup is identical to another benign clonic group, 24 where all seizures but one were bilateral and only two of the six occurred in full-term infants. Our findings appear to add support to the contention that clinical seizure semiology has a selective association with the ultimate neurodevelopmental outcome due to the presence of unique pathophysiologic processes for different seizure types. 13 However, within any semiologic grouping there is the potential for outcome to be affected by cumulative seizure activity occurring during the earlier more susceptible stages in brain development.
The size of the cohort does not allow complex analysis to separate independent from dependent variables. From our results five markers can be considered as predictive, mostly in keeping with earlier studies: the severity of the underlying etiology, brain maturity (preterm vs full term), abnormal interictal neonatal EEG, 2, 8, 25, 26 the lack of adequate seizure control with phenobarbital monotherapy, 3 and the presence or absence of specific seizure behaviors in either term or preterm infants. Outcome based on the combination of clinical, EEG, and imaging findings was suggested to be more reliable than using EEG 26 or possibly clinical criteria alone. Proton MR spectroscopic testing in proximity to the neonatal seizures and MRI may improve on the utility of the current markers to predict prognosis following neonatal seizures. 27 Neonates with seizures have few treatment options, because AEDs such as phenobarbital, phenytoin, and benzodiazepines rarely work by controlling epileptogenesis in newborns 3,28-30 and do not appear to improve outcome. Barbiturates and benzodiazepines increase the effect of GABA, which in the neonate may suppress the ictal clinical components through its inhibitory effect on spinal cord and brainstem. However, they do not necessarily suppress, and may even exacerbate, the ictal EEG because of the persistent excitatory effect of GABA in the cortical neurons due to their high intracellular Cl Ϫ . 31 As a result the clinical ictal events are often suppressed while EEG recordings may show ongoing cortical seizure activity (electroclinical dissociation). 3, 28, 29, 32 Novel therapies are needed, whether geared toward modulating intracellular Cl -homeostasis, 31 or strategies based on other cellular mechanisms. 33 Outcome data from this cohort may serve as a baseline for comparison in future intervention studies.
